A paper by Jun Kunisawa’s group (Division of Adjuvant Innvation) was published in International Immunopharmacology.

TLR4 agonist activity of Alcaligenes lipid a utilizes MyD88 and TRIF signaling pathways for efficient antigen presentation and T cell differentiation by dendritic cells

Sun X, Hosomi K, Shimoyama A, Yoshii K, Lan H, Wang Y, Yamaura H, Nagatake T, Ishii KJ, Akira S, Kiyono H, Fukase K, Kunisawa J.

Int Immunopharmacol. 2023 Apr;117:109852. doi: 10.1016/j.intimp.2023.109852. Epub 2023 Feb 18.